Avidity Biosciences Inc

NEW
NAS:RNA (USA)   Ordinary Shares
$ 28.57 -0.68 (-2.33%) 10:08 PM EST
At Loss
P/B:
2.40
Volume:
1.32M
Avg Vol (2M):
1.37M
Trade In:
Volume:
1.32M
At Loss
Avg Vol (2M):
1.37M

Business Description

Avidity Biosciences Inc
NAICS : 541714 SIC : 2834
ISIN : US05370A1088

Share Class Description:

RNA: Ordinary Shares
Description
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
Name Current Vs Industry Vs History
Cash-To-Debt 220.78
Equity-to-Asset 0.91
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 14.82
Distress
Grey
Safe
Beneish M-Score -0.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.73
Quick Ratio 15.73
Cash Ratio 15.32
Days Sales Outstanding 44.88

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -35.9
Shareholder Yield % -28.41

Financials (Next Earnings Date:2025-05-09 Est.)

RNA's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RNA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Avidity Biosciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10.897
EPS (TTM) ($) -2.89
Beta 1.07
3-Year Sharpe Ratio 0.59
3-Year Sortino Ratio 1.25
Volatility % 76.98
14-Day RSI 38.39
14-Day ATR ($) 1.830076
20-Day SMA ($) 31.8865
12-1 Month Momentum % 76.78
52-Week Range ($) 18.5601 - 56
Shares Outstanding (Mil) 120.21

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Avidity Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Avidity Biosciences Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Avidity Biosciences Inc Frequently Asked Questions

What is Avidity Biosciences Inc(RNA)'s stock price today?
The current price of RNA is $28.57. The 52 week high of RNA is $56.00 and 52 week low is $18.56.
When is next earnings date of Avidity Biosciences Inc(RNA)?
The next earnings date of Avidity Biosciences Inc(RNA) is 2025-05-09 Est..
Does Avidity Biosciences Inc(RNA) pay dividends? If so, how much?
Avidity Biosciences Inc(RNA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1